Sepsis Diagnostics Market Growth Set to Surge Significantly during (2017 - 2025)

Sepsis is a serious life threatening illness caused by the host immune system’s response to a
bacterial infection. Sepsis is among the most common causes of death in hospitals. Sepsis occurs
when the immune system of the host responds to an infection, and then chemicals are released by
the immune system to treat the infection. Upon entering the blood stream, this causes inflammation
throughout the body. It leads to blood clots, leakage in blood vessels and poor blood flow, and it
deprives the vital organs of the body of oxygen and nutrients.
Sepsis is considered as a three staged syndrome by many physicians starting with sepsis, leading to
severe sepsis, and finally septic shock, which is considered as a medical emergency. People with a
weak immune system, children, elderly people, and people with chronic diseases such as cancer,
AIDS, diabetes, etc. are among high risk of contracting sepsis.
The current methods of sepsis diagnostics rely on non-specific physiological and clinical criteria,
which many a times makes it difficult to differentiate sepsis, from a systematic inflammatory
response caused by normal inflammation. Blood test is the preliminary test for the evidence of
infection, clotting, and impaired oxygen availability. Other laboratory tests such as urine, wound
secretions and respiratory secretions are followed. If the confirmation of sepsis and the source of
inflammation is not found using these tests, then X-rays, Computerized Tomography, Ultrasound,
and Magnetic Resonance Imaging (MRI) are used.
A sample of this report is available upon request @
http://www.persistencemarketresearch.com/samples/13420
The global sepsis diagnostics market is segmented on the basis of product, by technology, by end
user, and by region. The product segments of the global sepsis diagnostics market are Assays and
Reagents, blood culture media, instruments, and others. Technology based segmentation of the
global sepsis diagnostics market is further classified into microbiology, molecular diagnostics, flow
cytometry, and Immunoassays.
The end users segmentation of the global sepsis diagnostics market is further segmented into
hospitals, specialty clinics, diagnostic centers, and pathology laboratories. Assays and reagents in
the products segment of the global sepsis diagnostics market dominated the global sepsis
diagnostics market in terms of revenue in 2015.
The high share of this segment is attributed to factors such as use of standard diagnostic methods in
the diagnosis, increasing usage of assays in the sepsis diagnosis, along with increasing number of
product approvals for marketing & commercialization globally. Molecular diagnostics is expected
to dominate the global sepsis diagnostics market by technology during the forecast period of 20162024. Technological advances in the field of molecular diagnostics, along with increasing need for
quick and accurate results, and inclination of doctors towards molecular diagnostic techniques for
diagnosis are factors which are anticipated to boost the growth of the segment through 2024.
On the basis of geography, the global sepsis diagnostics market is segmented in to five key regions,
North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America
dominated the global sepsis diagnostics market in 2015 in terms of value, owing to factors such as
increasing demand for better healthcare facilities, growing adoption of new and advanced
diagnostic techniques, high per capita healthcare expenditure, and increasing incidences of chronic
diseases such as cancer, diabetes, etc. leading to increasing hospital admissions and rising
incidences of hospital acquired infection in the U.S. Asia Pacific region is expected to register
highest CAGR during the forecast period of 2016-2024, owing to factors such as increasing
geriatric population in the region, combined with developing healthcare infrastructure, and
increasing prevalence of cancer and diabetes in countries such of India, China, and Australia.
However, lack of awareness and shortage of skilled workforce in the Asia Pacific regions are some
factors restraining the growth of the sepsis diagnostics market in this region.
To view TOC of this report is available upon request @
http://www.persistencemarketresearch.com/toc/13420
Some of the key players in the global sepsis diagnostics market include BioMérieux SA, Thermo
Fisher Scientific, Inc., T2 Biosystems, Inc., Nanosphere, Inc., Cepheid, Roche Diagnostics Limited,
Abbott Laboratories, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, and Bruker
Corporation among others.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a
unique collaboration of data analytics and market research methodology to help businesses achieve
optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary
approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying
real-time data collection, big data, and customer experience analytics, we deliver business
intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com